M. Gordon

发表

Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

J. Hardy, L. Buée, S. Younkin, 1996, Nature.

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

J. Hardy, S. Younkin, C. Eckman, 1998, Nature Medicine.

Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging

Susumu Mori, Paul Yarowsky, Peter C M van Zijl, 2004, Magnetic resonance in medicine.

Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis

J. Gestwicki, D. Morgan, M. Gordon, 2014, Journal of Neuroinflammation.

Amyloid, hyperactivity, and metabolism: theoretical comment on Vloeberghs et al. (2008).

D. Morgan, M. Gordon, 2008, Behavioral neuroscience.

Passive Amyloid Immunotherapy Clears Amyloid and Transiently Activates Microglia in a Transgenic Mouse Model of Amyloid Deposition

D. Wilcock, A. Rojiani, D. Morgan, 2004, The Journal of Neuroscience.

Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain

T. Golde, C. Ceballos‐Diaz, D. Morgan, 2010, Journal of Neuroscience Methods.

Mice expressing human mutant presenilin-1 exhibit decreased activation of NF-kappaB p50 in hippocampal neurons after injury.

C. Kassed, K. Pennypacker, D. Morgan, 2003, Brain research. Molecular brain research.

Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice.

P. Bickford, D. Diamond, M. Hutton, 2008, Journal of Alzheimer's disease : JAD.

Oral administration of green tea epigallocatechin-3-gallate (EGCG) reduces amyloid beta deposition in transgenic mouse model of Alzheimer's disease

J. Tan, D. Morgan, M. Gordon, 2006, Experimental Neurology.

Abnormal post‐translational and extracellular processing of brevican in plaque‐bearing mice over‐expressing APPsw

K. Pennypacker, D. Morgan, M. Gordon, 2010, Journal of neurochemistry.

Adeno-associated Viral ( AAV ) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces A β Deposits in APP + PS 1 Transgenic Mice

N. Muzyczka, C. Meyers, D. Morgan, 2022 .

Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice.

N. Muzyczka, C. Meyers, D. Morgan, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses

C. Colton, D. Wilcock, Qun Zhao, 2011, ASN neuro.

Behavioral consequences of ovarian atrophy and estrogen replacement in the APPswe mouse

P. Hoyer, M. Golub, L. Mayer, 2008, Neurobiology of Aging.

Impact of COVID‐19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research

M. Heneka, N. Terrando, M. Gordon, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Partial rescue of memory deficits induced by calorie restriction in a mouse model of tau deposition

R. Engelman, D. Morgan, M. Gordon, 2014, Behavioural Brain Research.

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice

C. Cao, D. Morgan, M. Gordon, 2022, International journal of molecular sciences.

Effects of Repetitive Exposure to Anesthetics and Analgesics in the Tg2576 Mouse Alzheimer’s Model

A. Paoli, E. Camporesi, D. Morgan, 2014, Neurotoxicity Research.

Chronological Age Impacts Immunotherapy and Monocyte Uptake Independent of Amyloid Load

J. Grimm, D. Morgan, M. Gordon, 2011, Journal of Neuroimmune Pharmacology.

Deglycosylated Anti-Aβ Antibody Dose–Response Effects on Pathology and Memory in APP Transgenic Mice

J. Grimm, J. Pons, D. Morgan, 2008, Journal of Neuroimmune Pharmacology.

A β vaccination, but not nitro-NSAID treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid.

D. Wilcock, D. Morgan, M. Gordon, 2008 .

Mice transgenic for a human amyloid precursor protein promoter-lacZ reporter construct

K. Duff, J. Salbaum, J. Goss, 1999, Journal of Molecular Neuroscience.

Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotection

G. Taglialatela, D. Wilcock, D. Morgan, 2007, Neurobiology of Disease.

Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain

D. Wilcock, D. Morgan, M. Gordon, 2006, Nature Protocols.

Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Aβ antibodies

K. Ugen, C. Cao, D. Morgan, 2007, BMC Neuroscience.

The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer's transgenic mice

M. Hutton, E. McGowan, G. Arendash, 2004, Neuroreport.

Increased Fibrillar β-Amyloid in Response to Human C1q Injections into Hippocampus and Cortex of APP+PS1 Transgenic Mice

D. Wilcock, D. Morgan, M. Gordon, 2004, Neurochemical Research.

Increased fibrillar beta-amyloid in response to human clq injections into hippocampus and cortex of APP+PS1 transgenic mice.

D. Wilcock, D. Morgan, M. Gordon, 2003, Neurochemical research.

Characterization of Amyloid Beta Vaccination Strategies in Mice

D. Wilcock, K. Ugen, C. Cao, 2003 .

Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.

D. Diamond, D. Wilcock, G. Arendash, 2001, DNA and cell biology.

Aβ and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity

S. Benkovic, D. Morgan, M. Gordon, 2000, Mechanisms of Ageing and Development.

CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model

D. Morgan, M. Gordon, K. Nash, 2018, Journal of Neuroimmune Pharmacology.

The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC

Yanhong Wang, C. Cao, D. Morgan, 2022, International journal of molecular sciences.

Intracranial Injection of AAV Expressing NEP but Not IDE Reduces Amyloid Pathology in APP+PS1 Transgenic Mice

D. Wilcock, D. Morgan, M. Gordon, 2013, PloS one.

Developmental expression of neural cell type‐specific mRNA markers in the myelin‐deficient mutant rat brain: Inhibition of oligodendrocyte differentiation

J. de Vellis, J. Vellis, M. Gordon, 1988, Journal of neuroscience research.

Microglia and immune activation in Alzheimer's disease.

M. Gordon, 1993, The Journal of the Florida Medical Association.

Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat

D. Morgan, M. Gordon, L. Holcomb, 1997, The Journal of comparative neurology.

Spontaneous tumors in aging female mice are more prevalent in the lateral pituitary zones

C. Finch, L. S. Felicio, M. Gordon, 1987, Neurobiology of Aging.

Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy

D. Morgan, M. Gordon, C. Dickey, 2015, The Journal of Neuroscience.

Transplantation of cultured premyelinating oligodendrocytes into normal and myelin-deficient rat brain.

J. de Vellis, M. Gordon, A. Espinosa de los Monteros, 1992, Developmental neuroscience.

Amyloid, Hyperactivity and Metabolism. A commentary on Vloebergh's et al.

D. Morgan, M. Gordon, Al, 2009 .

Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide.

D. Weiner, S. Kudchodkar, K. Ugen, 2001, DNA and cell biology.

Short-term β-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP+PS1 mice

D. Diamond, K. Ugen, G. Arendash, 2003 .

Biochemical and Histochemical Evidence of Nonspecific Binding of α7nAChR Antibodies to Mouse Brain Tissue

E. Severance, J. Cuevas, D. Morgan, 2004 .

Is ethylcholine mustard aziridinium ion a specific cholinergic neurotoxin?

L. Butcher, P. Kelly, S. McGurk, 1987, Neuroscience.

Effective oral administration of 17 beta-estradiol to female C57BL/6J mice through the drinking water.

C. Finch, P. May, M. Gordon, 1986, Biology of reproduction.

Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice.

D. Diamond, K. Ugen, G. Arendash, 2003, Behavioral neuroscience.

Microglial Activation is Required for Aβ Clearance After Intracranial Injection of Lipopolysaccharide in APP Transgenic Mice

D. Morgan, M. Gordon, M. Freeman, 2007, Journal of Neuroimmune Pharmacology.

Adeno associated viral-mediated intraosseous labeling of bone marrow derived cells for CNS tracking.

D. Morgan, M. Gordon, Daniel C Lee, 2016, Journal of immunological methods.

Ontogeny of glycerol phosphate dehydrogenasepositive oligodendrocytes in rat brain. Impaired differentiation of oligodendrocytes in the myelin deficient mutant rat

S. Kumar, J. Vellis, M. Gordon, 1992, International Journal of Developmental Neuroscience.

Convection Enhanced Delivery of Recombinant Adeno-associated Virus into the Mouse Brain.

M. Gordon, K. Nash, 2016, Methods in molecular biology.

Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapy

X. Chen, Shufeng Zhou, C. Cao, 2015, Oncotarget.

Pituitary and hypothalamic glucose-6-phosphate dehydrogenase: effects of estradiol and age in C57BL/6J mice.

C. Finch, C. Mobbs, M. Gordon, 1988, Endocrinology.

Neural atrophy produced by AAV tau injections into hippocampus and anterior cortex of middle-aged mice

A. Tetlow, D. Morgan, M. Gordon, 2022, Neurobiology of Aging.

Contrasting In Vivo Effects of Two Peptide-Based Amyloid-β Protein Aggregation Inhibitors in a Transgenic Mouse Model of Amyloid Deposition

D. Morgan, M. Gordon, R. Hammer, 2008, Cell transplantation.

Diverse microglial responses after intrahippocampal administration of lipopolysaccharide

D. Morgan, M. Gordon, M. Freeman, 2006, Glia.

Dynamic Complexity of the Microglial Activation Response in Transgenic Models of Amyloid Deposition: Implications for Alzheimer Therapeutics

D. Wilcock, A. Rojiani, D. Morgan, 2005, Journal of neuropathology and experimental neurology.

Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer’s Disease: A Targeted Transcriptome Analysis

P. Bickford, J. Gensel, D. Feola, 2021, Frontiers in Immunology.

Concentration and proteolysis of CX3CL1 may regulate the microglial response to CX3CL1

P. Bickford, D. Morgan, M. Gordon, 2022, Glia.

CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model

D. Morgan, M. Gordon, K. Nash, 2018, Journal of Neuroimmune Pharmacology.

Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy

P. Bickford, D. Morgan, M. Gordon, 2013, Neurobiology of Aging.

Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes

D. Diamond, C. Hope, G. Arendash, 2001, Brain Research.

Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal Pathway

E. Mufson, S. Counts, D. Morgan, 2001, Experimental Neurology.

CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy

D. Morgan, M. Gordon, A. Joly-Amado, 2020, Frontiers in Immunology.

Metabolic changes over the course of aging in a mouse model of tau deposition

J. Speakman, D. Morgan, M. Gordon, 2016, Neurobiology of Aging.

Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer’s Pathology

Leif Benner, D. Morgan, M. Gordon, 2013, PloS one.

Aging enhances classical activation but mitigates alternative activation in the central nervous system

D. Morgan, M. Gordon, C. Dickey, 2013, Neurobiology of Aging.

LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice

D. Morgan, M. Gordon, C. Dickey, 2010, Journal of Neuroinflammation.

Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice

D. Diamond, D. Wilcock, D. Morgan, 2006, Nature Protocols.

Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse

James P. O'Callaghan, Dave Morgan, J. O'Callaghan, 2002, Experimental Neurology.

Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease

D. Boche, M. Gordon, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Regional and Cellular Localization of Presenilin-2 RNA in Rat and Human Brain

N. Rothwell, M. Hutton, E. McGowan, 1997, Experimental Neurology.

Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

S. Paul, K. Bales, H. Potter, 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Neuregulin–1 and ErbB4 Immunoreactivity Is Associated with Neuritic Plaques in Alzheimer Disease Brain and in a Transgenic Model of Alzheimer Disease

S. Carroll, A. Chaudhury, D. Morgan, 2003, Journal of neuropathology and experimental neurology.

Radiation-induced senescence: therapeutic opportunities

M. Gordon, S. Brown, Jae Ho Kim, 2023, Radiation Oncology.

Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain

P. Mouton, C. Cao, D. Morgan, 2013, Journal of Neuroinflammation.

Transcriptional regulation studies of myelin-associated genes in myelin-deficient mutant rats.

J. de Vellis, W. Macklin, M. Gordon, 1990, Developmental neuroscience.

Amyloid‐β protofibril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic mice

L. Lannfelt, L. Hillered, D. Morgan, 2009, The FEBS journal.

The antiestrogen LY117018 blocks effects of estradiol on pituitary glucose-6-phosphate dehydrogenase specific activity and on serum LH.

C. Finch, C. Mobbs, M. Gordon, 1985, Neuroendocrinology.

α-1-Antichymotrypsin Promotes β-Sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer's Disease

S. Paul, K. Bales, H. Potter, 2001, The Journal of Neuroscience.

Complement C1qB and C4 mRNAs responses to lesioning in rat brain

David A. Willoughby, C. Finch, G. Pasinetti, 1992, Experimental Neurology.

Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models

T. Morgan, C. Finch, R. Engelman, 2005, Neurobiology of Aging.

Oligomeric tau-targeted immunotherapy in Tg4510 mice

U. Sengupta, D. Morgan, M. Gordon, 2017, Alzheimer's Research & Therapy.

Suppression of Amyloid Deposition Leads to Long-Term Reductions in Alzheimer's Pathologies in Tg2576 Mice

J. Pons, D. Morgan, M. Gordon, 2009, The Journal of Neuroscience.

Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic Mice

K. Szekeres, J. Koren, D. Morgan, 2010, The Journal of Neuroscience.

Arginase 1 Insufficiency Precipitates Amyloid-β Deposition and Hastens Behavioral Impairment in a Mouse Model of Amyloidosis

P. Bickford, J. Gensel, D. Feola, 2021, Frontiers in Immunology.

Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice

J. Loring, D. Morgan, M. Gordon, 2003, The Journal of Neuroscience.

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

J. Hardy, D. Diamond, D. Wilcock, 2000, Nature.

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

J. Hardy, D. Diamond, D. Wilcock, 2000, Nature.

Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice

D. Wilcock, D. Morgan, M. Gordon, 2001, Neurobiology of Aging.

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice

D. Wilcock, D. Morgan, M. Gordon, 2005, BMC Neuroscience.

An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β.

Phillip D. Pham, Xiaopeng Li, C. Cao, 2020, Journal of Alzheimer's disease : JAD.

Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice

J. Guzowski, D. Diamond, D. Morgan, 2003, Journal of neurochemistry.

Review: Experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology

D. Morgan, M. Gordon, M. Selenica, 2013, Neuropathology and applied neurobiology.

The Amyloid Hypothesis of Cognitive Dysfunction

D. Morgan, M. Gordon, 2003 .

Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice

D. Diamond, C. Hope, G. Arendash, 2001, Neurobiology of Aging.

Behavioral Changes in Transgenic Mice Expressing Both Amyloid Precursor Protein and Presenilin-1 Mutations: Lack of Association with Amyloid Deposits

K. Duff, D. Morgan, K. Hsiao, 1999, Behavior genetics.

Associative and motor learning in 12-month-old transgenic APP+PS1 mice

M. Ewers, D. Woodruff-Pak, D. Morgan, 2006, Neurobiology of Aging.

Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence

T. L. Taylor, C. Colton, D. Wilcock, 2011, Journal of Neuroinflammation.

Topochemical localization of choline acetyltransferase and acetylcholinesterase in mouse brain

C. Finch, M. Gordon, 1984, Brain Research.

Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology

N. Petrovsky, D. Cribbs, D. Morgan, 2020, Neurobiology of Disease.

Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer’s Disease and Other Tauopathies

D. Morgan, M. Gordon, A. Joly-Amado, 2015, Journal of Neuroimmune Pharmacology.

Intracranial administration of deglycosylated C-terminal-specific antiA β antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice

Jan Grimm, Dave Morgan, J. Grimm, 2015 .

Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice

J. Schiller, K. Ugen, C. Cao, 2004, BMC Neuroscience.

Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging

B. Winblad, C. Finch, J. Marcusson, 1987, Neurobiology of Aging.

Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

D. Wilcock, A. Rojiani, D. Morgan, 2004, Journal of Neuroinflammation.

Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation

Dave Morgan, D. Wilcock, K. Ugen, 2003, The Journal of Neuroscience.

Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.

D. Wilcock, K. Ugen, D. Morgan, 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels.

D. Wilcock, K. Ugen, J. Hardy, 2001, DNA and cell biology.

Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer’s Disease and Other Tauopathies

D. Morgan, M. Gordon, A. Joly-Amado, 2016, Journal of Neuroimmune Pharmacology.

Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy

D. Morgan, M. Gordon, C. Dickey, 2012, Neurodegenerative Diseases.

Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and trimethyltin-induced brain injury

J. O'Callaghan, K. Pennypacker, S. Benkovic, 2000, Neuroscience.

Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice

D. Morgan, M. Gordon, David Wilson, 2004, Experimental Neurology.

Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice

D. Coppola, J. Wallace, G. Wenk, 2002, The Journal of Neuroscience.

Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice

E. Weeber, D. Morgan, M. Gordon, 2021, GeroScience.

Unbiased estimation of cell number using the automatic optical fractionator

Lawrence O. Hall, Hady Ahmady Phoulady, Peter R. Mouton, 2017, Journal of Chemical Neuroanatomy.

Spermidine/spermine-N1-acetyltransferase ablation impacts tauopathy-induced polyamine stress response

E. Weeber, D. Morgan, M. Gordon, 2019, Alzheimer's Research & Therapy.

Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition

A. Kozikowski, Leif Benner, D. Morgan, 2014, Alzheimer's Research & Therapy.

Blueberry Supplementation Enhances Signaling and Prevents Behavioral Deficits in an Alzheimer Disease Model

B. Shukitt-Hale, J. Joseph, D. Diamond, 2003, Nutritional neuroscience.

The myelin-deficient rat mutant: partial recovery of oligodendrocyte maturation in vitro.

J. de Vellis, M. Gordon, S. Scully, 1990, Developmental neuroscience.

Disruption of normal circadian clock function in a mouse model of tauopathy

J. Gamsby, D. Morgan, M. Gordon, 2017, Experimental Neurology.

Biochemical and histochemical evidence of nonspecific binding of alpha7nAChR antibodies to mouse brain tissue.

E. Severance, J. Cuevas, D. Morgan, 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Oligomeric tau-targeted immunotherapy in Tg4510 mice

U. Sengupta, D. Morgan, M. Gordon, 2017, Alzheimer's Research & Therapy.

Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition

A. Kozikowski, Leif Benner, D. Morgan, 2014, Alzheimer's Research & Therapy.

Virus-like Peptide Vaccines Against Aß N-terminal or C-Terminal Domains Reduce Amyloid Deposition in APP Transgenic Mice without Addition of Adjuvant

K. Ugen, D. Morgan, M. Gordon, 2010, Journal of Neuroimmune Pharmacology.

Deglycosylated Anti-Amyloid-β Antibodies Eliminate Cognitive Deficits and Reduce Parenchymal Amyloid with Minimal Vascular Consequences in Aged Amyloid Precursor Protein Transgenic Mice

J. Grimm, D. Wilcock, J. Pons, 2006, The Journal of Neuroscience.

Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration

D. Wilcock, K. Ugen, D. Morgan, 2004, Neurobiology of Disease.

Impaired spatial navigation learning in transgenic mice over-expressing heme oxygenase-1

M. Maines, D. Morgan, M. Gordon, 1998, Brain Research.

Effects of Repetitive Exposure to Anesthetics and Analgesics in the Tg2576 Mouse Alzheimer’s Model

A. Paoli, E. Camporesi, D. Morgan, 2014, Neurotoxicity Research.

Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration.

D. Wilcock, K. Ugen, D. Morgan, 2004, Neurobiology of disease.

Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid.

D. Wilcock, D. Morgan, M. Gordon, 2007, Neuroscience.

Chronological Age Impacts Immunotherapy and Monocyte Uptake Independent of Amyloid Load

J. Grimm, D. Morgan, M. Gordon, 2012, Journal of Neuroimmune Pharmacology.

Spermidine/spermine-N1-acetyltransferase ablation impacts tauopathy-induced polyamine stress response

E. Weeber, D. Morgan, M. Gordon, 2019, Alzheimer's Research & Therapy.

A b peptide vaccination prevents memory loss in an animal model of Alzheimer ' s disease

D. Diamond, D. Wilcock, C. Hope, 2001 .

Oral Versus Transdermal Selegiline Antidepressant-Like Activity in Rats

A. Azzaro, D. Morgan, M. Gordon, 1999, Pharmacology Biochemistry and Behavior.

correction: Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

J. Hardy, D. Diamond, D. Wilcock, 2001, Nature.

Genotypic influences on pituitary responsiveness to haloperidol in mice

C. Finch, P. Randall, D. Morgan, 1987, Psychoneuroendocrinology.

Activation of matrix metalloproteinases following antiA b immunotherapy ; implications for microhemorrhage occurrence

C. Colton, D. Wilcock, D. Wink, 2015 .

Developmental regulation of myelin-associated genes in the normal and the myelin deficient mutant rat.

J. de Vellis, M. Gordon, S. Scully, 1990, Advances in experimental medicine and biology.

Intracranial administration of deglycosylated C-terminal-specific antiA β antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice

J. Grimm, D. Wilcock, J. Pons, 2015 .

Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.

D. Morgan, M. Gordon, Amber M. Tetlow, 2023, Journal of Alzheimer's disease : JAD.

Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice

J. Schiller, K. Ugen, C. Cao, 2004, BMC Neuroscience.

Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

D. Wilcock, A. Rojiani, D. Morgan, 2004, Journal of Neuroinflammation.

Toward Development of Neuron Specific Transduction After Systemic Delivery of Viral Vectors

D. Morgan, M. Gordon, K. Nash, 2021, Frontiers in Neurology.

Aging enhances classical activation but mitigates alternative activation in the central nervous system

D. Morgan, M. Gordon, C. Dickey, 2013, Neurobiology of Aging.

New approaches to the study of central nervous system function. Immune-nervous system interactions and cell culture

D. Morgan, M. Gordon, 1988, Neurobiology of Aging.

Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses

C. Colton, D. Wilcock, Qun Zhao, 2011, ASN neuro.